查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1923039

伊塞颗粒剂市场按产品配方、剂量强度、适应症类别、最终用户和分销管道划分－2026-2032年全球预测

Yiqing Keli Market by Product Formulation, Dosage Strength, Indication Category, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年 Issei 颗粒剂市场规模为 1.0215 亿美元，预计到 2026 年将成长至 1.104 亿美元，到 2032 年将达到 1.6528 亿美元，复合年增长率为 7.11%。

关键市场统计数据
基准年 2025 1.0215亿美元
预计年份：2026年 1.104亿美元
预测年份 2032 1.6528亿美元
复合年增长率 (%) 7.11%

该研究以简洁的策略叙述形式进行了总结，为高阶主管提供了确定优先事项和有效分配资源所需的关键见解。

本执行摘要综合了关键的策略和营运洞察，旨在为经营团队、产品团队和商业职能部门提供明智的决策支援。它整合了观察到的行业趋势、结构性变化和实际影响，帮助读者加快关键业务领域的专案优先排序、资源分配和价值实现速度。此分析着重于可操作性的清晰阐述；它并非详尽的清单，而是重点关注最有可能在中短期内影响竞争地位的趋势和转折点。

了解技术、监管和地缘政治重组的整合动态，这些动态正在推动竞争、韧性和创新的持久变革。

市场格局正经历着一场由多种因素共同驱动的变革：技术应用、不断演变的监管环境以及不断变化的客户期望，这些因素正在重塑竞争格局。数位化的加速正推动解决方案从点解决方案转型为平台。云端原生架构和API优先模式能够实现更快的产品迭代和更强大的生态系统整合。同时，人工智慧和进阶分析技术正从实验性试点走向成熟，成为流程自动化、风险管理和客户体验优化等关键要素，从而提高了差异化和营运韧性的标准。

评估2025年关税调整对筹资策略、供应链设计和采购实务的影响，并考虑其连锁营运后果。

美国于2025年实施的一系列关税措施的累积影响已波及供应链、筹资策略和成本转嫁动态，对企业的营运和策略产生了多方面的影响。首先，采购团队被迫重新评估采购决策，以平衡成本、前置作业时间和供应商集中度风险，许多企业正在加速采购多元化或探索其他地理以降低风险。这导致企业更加关注总到岸成本分析而非基本单位成本，并迫使采购和财务负责人将情境规划和压力测试纳入供应商选择流程。

透过细緻的细分洞察，制定有针对性的策略行动，使产品设计、定价和通路策略与买家的独特需求和实施偏好保持一致。

细分市场层面的清晰认知使领导者能够根据特定买家的行为和技术需求，客製化市场推广策略和产品设计决策。透过按应用程式、部署类型和使用案例进行分析，可以揭示指南优先顺序排序的模式。例如，面向银行和金融服务的专用解决方案需要严格的安全性和合规性功能；医疗保健部署优先考虑互通性和患者资料保护；製造业强调确定性效能和与操作技术堆迭的整合；而电子商务零售则需要可扩展性和低延迟交易处理。这些特定于应用的需求塑造了产品蓝图，并决定了哪些整合投资能带来最大的回报。

绘製美洲、欧洲、中东和非洲以及亚太地区的区域趋势和合作伙伴生态系统图，以协助制定差异化的打入市场策略和合规策略。

区域差异持续影响需求模式、合作伙伴生态系统和监管风险，因此美洲、欧洲、中东和非洲以及亚太地区需要采取差异化的策略。在美洲，成熟的采购週期和成熟的供应商生态系统有利于规模较大的企业以及能够展现出可衡量的效率和合规优势的解决方案。北美企业通常率先采用云端优先策略，同时密切关注资料居住和隐私框架。同时，在拉丁美洲市场，商业和金融服务的数位化带来了成长机会，但也需要企业适应当地的支付系统和分销模式。

透过整合解决方案、合作伙伴赋能和服务主导成长来评估竞争差异化优势，从而影响客户获取和保留。

该领域的竞争格局呈现出平台整合、选择性伙伴关係以及对服务能力进行定向投资的多元化特征。市场领导正积极推广整合解决方案，将核心产品功能与专业服务结​​合，以加速部署并提升产品生命週期价值。同时，敏捷的新兴企业则凭藉其领域专长和创新的定价及部署模式，成功赢得特定垂直市场的客户。跨云端服务供应商、系统整合商和通路网路的策略伙伴关係正变得日益重要，从而能够在复杂的企业环境中提供更广泛的分销和部署支援。

透过实施切实可行的策略性措施和营运转型，增强产品差异化、通路绩效和顾客成果，进而建立强大的竞争优势。

产业领导者应优先采取一系列策略行动，将洞察转化为可持续的竞争优势。首先，将产品蓝图与最严苛的垂直市场需求相匹配，从而打造可防御的差异化优势，并确立高端定位。这需要与领域专家和客户持续互动，共同打造能够减少整合摩擦并增强合规性的能力。其次，透过按能力和帐户类型细分合作伙伴、投资赋能以及製定促进长期合作而非交易协议的通用成功指标，优化通路策略。第三，采用能反映不同买家偏好的弹性定价结构。订阅和按使用量付费相结合的方式，既能扩大目标市场，又能维持稳定的收入来源。

本执行摘要详细介绍了一个混合方法研究框架，该框架结合了主要访谈、次要分析和交叉检验综合，以产生可操作和可靠的研究结果。

本执行摘要的研究结合了定性和定量方法，以确保其稳健性和实用性。主要研究包括对行业高管、采购人员和系统整合商进行结构化访谈，以收集关于采用驱动因素、实施难点和供应商选择标准的第一手资讯。次要研究整合了公开文件、监管指南、技术白皮书和案例研究，以验证论点并提供更深入的背景资讯。资料整合强调跨资讯来源的交叉检验，以减少单一资讯来源偏差，并突出趋同征兆而非孤立的个案。

总结关键策略重点，将研究成果转化为具体行动，以增强韧性、实现差异化并创造长期价值。

本执行摘要提出的全面观点明确指出，在动态互联的市场中运作的企业必须满足几个关键要求。首先，企业必须在产品、供应链和商业模式中建立韧性和敏捷性，以应对关税波动、地缘政治不确定性和加速的技术变革。其次，以客户为中心、基于垂直整合的功能、安全性和结果导向服务的差异化策略，能够打造具有竞争力的价值提案，从而支撑高定价和高客户维繫。第三，通路和策略伙伴需要有针对性的投资和支持，以将生态系统关係转化为稳定的收入来源和执行能力。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 伊势颗粒剂市场依产品配方划分

  • 标准颗粒
    • 糖衣颗粒
    • 无糖颗粒
  • 儿童颗粒剂
    • 低剂量儿童颗粒剂
    • 标准儿童颗粒
  • 胶囊
    • 硬胶囊
    • 软胶囊
  • 口服液
    • 可饮用溶液
    • 浓缩液

9. 一政颗粒剂市场（以剂量强度划分）

  • 低强度
  • 标准强度
  • 高强度
  • 滴定剂量包

第十章 伊塞颗粒剂市场依适应症分类

  • 上呼吸道感染疾病
    • 寒冷的
    • 急性咽头炎
    • 急性扁桃腺炎
  • 类流感疾病
    • 季节性流感
    • 病毒性发热
  • 下呼吸道併发症
    • 急性支气管炎
    • 慢性支气管炎急性发作
  • 预防性使用
    • 免疫支持
    • 暴露后预防

第十一章 伊势颗粒剂市场（以最终用户划分）

  • 医院
  • 诊所
    • 一般诊所
    • 耳鼻喉科诊所
    • 中医诊所
  • 家用

第十二章 宜清颗粒市场（依通路划分）

  • 医院药房
  • 零售药房
  • 中医诊所
  • 网路药房

第十三章 各地区伊势颗粒市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 伊势颗粒市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国一成颗粒剂市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 美国宜清颗粒市场

第十七章 中国宜清颗粒市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Anguo Yadong Biopharmaceutical Co., Ltd.
  • Guangdong Luofushan National Pharmaceutical Co., Ltd.
  • Guizhou Hengba Pharmaceutical Co., Ltd.
  • Jiangxi Huiren Pharmaceutical Co., Ltd.
  • Jiangxi Xinglin Baima Pharmaceutical Co., Ltd.
  • Jilin Gaomiao Pharmaceutical Co., Ltd.
  • Mengyang Pharmaceutical Co., Ltd.
  • Qionglai Tianyin Pharmaceutical Co., Ltd.
  • Shanxi Jinxin Shuanghe Pharmaceutical Co., Ltd.
  • Tonghua Hongbao Pharmaceutical Co., Ltd.
  • Tonghua Jinkaiwei Pharmaceutical Co., Ltd.
  • Tonghua Jinma Pharmaceutical Group Co., Ltd.
  • Yunnan Xitao Green Pharmaceutical Co., Ltd.
  • Zhejiang Weikang Pharmaceutical Co., Ltd.
Product Code: MRR-867BED9A9EE6

The Yiqing Keli Market was valued at USD 102.15 million in 2025 and is projected to grow to USD 110.40 million in 2026, with a CAGR of 7.11%, reaching USD 165.28 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 102.15 million
Estimated Year [2026] USD 110.40 million
Forecast Year [2032] USD 165.28 million
CAGR (%) 7.11%

Framing the research into a concise strategic narrative that equips senior leaders with the essential insights needed to prioritize initiatives and allocate resources effectively

This executive summary consolidates critical strategic and operational insights to support informed decision-making across senior leadership, product teams, and commercial functions. It synthesizes observed industry dynamics, structural shifts, and practical implications so that readers can prioritize initiatives, allocate resources, and accelerate time-to-value across core business lines. The analysis emphasizes actionable clarity: rather than exhaustive enumeration, it highlights the trends and inflection points most likely to influence competitive positioning over the near to medium term.

The objective is to provide a compact, analytically rigorous narrative that bridges research findings with pragmatic next steps. Throughout the summary, evidence is used to illustrate causal relationships between macro drivers and enterprise outcomes, and transitional language is applied to ensure a logical progression from context to implications and recommendations. Decision-makers will find this resource useful as both a briefing document for stakeholder alignment and a reference for developing strategic responses to fast-evolving external conditions.

Understanding the convergent forces of technology, regulation, and geopolitical realignment that are driving durable shifts in competition, resilience, and innovation

Market landscapes are undergoing transformative shifts driven by technology adoption, regulatory evolution, and changing customer expectations, each interacting to reshape the competitive environment. Digital acceleration is moving beyond point solutions and toward platformization, as cloud-native architectures and API-first models enable faster product iteration and tighter ecosystem integration. Concurrently, artificial intelligence and advanced analytics are maturing from experimental pilots to mission-critical components in process automation, risk management, and customer experience optimization, thereby raising the bar for differentiation and operational resilience.

Regulatory and compliance regimes are converging with data protection imperatives, prompting greater investment in governance, privacy engineering, and auditability. This creates both a compliance burden and a market opportunity for vendors that can embed demonstrable controls into their solutions. Geopolitical dynamics and supply-chain recalibration are incentivizing diversification of sourcing strategies and investment in resilience, which in turn influence cost structures and strategic partnerships. As a result, organizations must rethink vendor selection criteria to include geopolitical risk assessments, service continuity guarantees, and transparent procurement pathways. Finally, the talent landscape is shifting in response to these changes, with cross-functional capabilities that combine domain knowledge, data fluency, and security expertise becoming essential for sustained innovation and risk mitigation.

Assessing how 2025 tariff adjustments have reshaped sourcing strategies, supply chain design, and procurement practices with cascading operational consequences

The cumulative impact of recent tariff measures implemented by the United States in 2025 has propagated through supply chains, procurement strategies, and cost pass-through dynamics, producing several operational and strategic effects for firms. First, procurement teams have had to reassess sourcing decisions to balance cost, lead times, and supplier concentration risk, with many organizations accelerating diversification efforts or exploring alternative geographies to mitigate exposure. This has increased focus on total landed cost analysis rather than base unit pricing, pushing procurement and finance leaders to integrate scenario planning and stress testing into vendor selection.

Second, the tariffs have intensified conversations about nearshoring and regional manufacturing capacity, prompting some firms to evaluate the trade-offs between higher local labor and facility costs and the advantages of reduced transit times, lower inventory buffers, and improved supply-chain visibility. In parallel, affected companies have increased attention to product architecture and bill-of-materials optimization to identify components that present the highest tariff sensitivity and to redesign for modularity or substitution where feasible. Finally, compliance and customs functions have scaled up capabilities to manage classification, valuation, and duty optimization, while finance teams have worked to determine appropriate customer communication strategies around potential price adjustments and to preserve margins without undermining demand.

Deriving targeted strategic actions from granular segmentation insights that align product design, pricing, and channel strategies with distinct buyer needs and deployment preferences

Segment-level clarity enables leaders to tailor go-to-market approaches and product design decisions to specific buyer behaviors and technical requirements. When analyzed by application, deployment, and use case, patterns emerge that inform prioritization: for example, solutions tailored for banking and financial services demand stringent security and compliance features, whereas healthcare implementations prioritize interoperability and patient data safeguards, manufacturing emphasizes deterministic performance and integration with operational technology stacks, and retail ecommerce requires scalability and low-latency transaction processing. These application-specific requirements shape product roadmaps and determine which integration investments yield the highest return.

Enterprise size and end-user classifications further nuance positioning decisions, as the needs of large enterprises diverge from those of medium and small firms in procurement cycles, customization expectations, and purchasing authority. Large organizations typically seek enterprise-grade SLAs, extensive professional services, and complex integration plans, while medium and small enterprises often prioritize ease of deployment, cost predictability, and rapid time-to-value. Deployment mode choices also influence adoption pathways: cloud, hybrid, and on-premise options respond to different risk appetites and operational constraints, and within cloud environments the distinction between private and public architectures affects governance models and total cost considerations. Sales channel economics are equally important; channel partners, including distributors, system integrators, and value added resellers, play a decisive role in market reach and implementation success, whereas direct sales and online channels can drive higher margin but require stronger brand trust and self-service capabilities. Pricing models-perpetual license, subscription, and usage-based-should align with buyer cash-flow preferences and expected consumption patterns, with hybrid pricing often appropriate for mixed-use scenarios. Finally, component-level segmentation across hardware, services, and software highlights the importance of services subcategories such as consulting, integration, and maintenance and support, since these offerings frequently determine post-sale satisfaction and long-term retention rates.

Mapping regional dynamics and partner ecosystems across the Americas, Europe Middle East & Africa, and Asia-Pacific to inform differentiated go-to-market and compliance strategies

Regional variation continues to shape demand patterns, partner ecosystems, and regulatory exposure, requiring differentiated strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, established procurement cycles and mature vendor ecosystems favor scale players and solutions that demonstrate measurable efficiency and compliance benefits; North American firms are often early adopters of cloud-first approaches but remain attentive to data residency and privacy frameworks. Meanwhile, Latin American markets present growth opportunities driven by digitalization of commerce and financial services, but they also require adaptations for local payment systems and distribution models.

In Europe, Middle East & Africa, regulatory complexity and diversity of market maturity necessitate localized go-to-market structures and deeper partner collaboration, with data protection regulations and regional trade arrangements influencing deployment and integration decisions. The Middle East is notable for strategic investments in digital infrastructure and sovereign cloud initiatives, which create opportunities for tailored partnerships. Asia-Pacific encompasses both highly sophisticated markets that prioritize cutting-edge automation and emerging markets where cost-sensitive adoption and mobile-first architectures dominate; regional supply-chain roles and manufacturing capacity also make this region central to sourcing and production strategies. Successful regional approaches blend global platform capabilities with local compliance, partner enablement, and go-to-market customization.

Evaluating competitive differentiation driven by integrated solution sets, partner enablement, and service-led growth that influence customer acquisition and retention

Competitive behavior in the sector is characterized by a mix of platform consolidation, selective partnerships, and targeted investments in services capabilities. Market leaders are advancing integrated solution sets that combine core product functionality with professional services to shorten implementation timelines and increase lifetime value. At the same time, nimble challengers are leveraging focused domain expertise or innovative pricing and deployment models to win specific vertical accounts. Strategic partnerships-across cloud providers, systems integrators, and channel networks-are increasingly decisive, since they enable broader distribution and provide implementation muscle in complex enterprise environments.

Organizational differentiation is also increasingly achieved through investments in developer ecosystems, certification programs, and partner enablement that reduce friction for system integrators and value added resellers. Companies that systematically capture implementation knowledge and translate it into reusable assets and preconfigured integrations gain competitive advantage by lowering deployment risk and accelerating customer onboarding. Moreover, firms that invest in transparent security and compliance practices secure trust with large enterprises and regulated industries, thereby unlocking enterprise pipeline opportunities. Finally, leadership in customer success functions-measured through structured onboarding, outcome-based contracts, and ongoing advisory relationships-proves to be a durable moat that supports upsell and retention.

Implement pragmatic strategic moves and operational changes that strengthen product differentiation, channel performance, and customer outcomes to build resilient competitive advantage

Industry leaders should prioritize a set of strategic actions that convert insight into durable advantage: first, align product roadmaps with the most demanding vertical requirements to create defensible differentiation and to justify premium positioning. This requires ongoing engagement with domain experts and customers to co-create features that reduce integration friction and improve compliance posture. Second, optimize channel strategy by segmenting partners by capability and account type, investing in enablement, and developing shared success metrics that incentivize long-term collaboration rather than transactional deals. Third, adopt flexible pricing architectures that reflect diverse buyer preferences: combinations of subscription and usage-based elements can expand addressable markets while preserving predictable revenue streams.

Operationally, leaders should strengthen procurement and supply-chain agility by diversifying supplier bases and accelerating bill-of-materials rationalization to reduce tariff exposure and lead-time vulnerabilities. Complementary investments in governance, privacy engineering, and security-by-design will reduce friction in highly regulated industries and support faster enterprise sales cycles. Finally, build a customer success engine that measures and monetizes outcomes, leveraging playbooks, automated onboarding, and outcome-based service tiers to protect retention and increase lifetime value. These actions, implemented in a staged and cross-functional manner, will position organizations to respond to market volatility while creating enduring competitive barriers.

Detailing a mixed-methods research framework combining primary interviews, secondary analysis, and cross-validated synthesis to produce actionable, reliable insights

The research underpinning this executive summary combined qualitative and quantitative approaches to ensure robustness and practical relevance. Primary research included structured interviews with industry executives, procurement leaders, and systems integrators to capture firsthand perspectives on adoption drivers, implementation friction points, and vendor selection criteria. Secondary analysis incorporated public filings, regulatory guidance, technology white papers, and case studies to triangulate claims and to create contextual depth. Data synthesis emphasized cross-validation across sources to reduce single-source bias and to highlight convergent signals rather than isolated anecdotes.

Analytical methods included thematic coding of qualitative input, comparative scenario analysis to assess strategic options, and value-chain mapping to identify where cost and risk concentrations exist. Segmentation decisions were driven by buyer behavior, deployment patterns, and typical procurement workflows, and the methodology deliberately distinguished between enterprise size, deployment mode, application needs, pricing models, sales channels, and component-level economics. Limitations of the approach are acknowledged: while the research captures prevailing dynamics and directional impacts, granular financial metrics and proprietary customer-level data fall outside the scope of this summary. Accordingly, the findings are intended to guide strategic prioritization and hypothesis formation rather than to serve as a definitive financial forecast.

Summarizing the essential strategic priorities that convert research findings into concrete actions for building resilience, differentiation, and long-term value

The cumulative narrative presented in this executive summary points to several clear imperatives for organizations operating in dynamic and interconnected markets. First, resilience and agility must be engineered into product, supply chain, and commercial models to withstand tariff shifts, geopolitical uncertainty, and accelerating technological change. Second, customer-centric differentiation-anchored in verticalized functionality, security, and outcome-based services-creates defensible value propositions that support premium pricing and higher retention. Third, channel and partner strategies require curated investments and enablement to convert ecosystem relationships into reliable revenue and implementation capacity.

In closing, the most successful organizations will be those that translate strategic intent into operational capabilities: they will prioritize investments that reduce time-to-value for customers, diversify supply and vendor exposure to minimize single points of failure, and enhance governance and compliance to lower adoption friction in regulated industries. By focusing on these priorities with disciplined execution, leaders can transform uncertainty into opportunity and sustain competitive advantage through both incremental optimization and targeted innovation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Yiqing Keli Market, by Product Formulation

  • 8.1. Standard Granule
    • 8.1.1. Sugar-Coated Granule
    • 8.1.2. Sugar-Free Granule
  • 8.2. Pediatric Granule
    • 8.2.1. Low-Dose Pediatric Granule
    • 8.2.2. Standard Pediatric Granule
  • 8.3. Capsule
    • 8.3.1. Hard Capsule
    • 8.3.2. Soft Capsule
  • 8.4. Oral Solution
    • 8.4.1. Ready-to-Drink Solution
    • 8.4.2. Concentrated Solution

9. Yiqing Keli Market, by Dosage Strength

  • 9.1. Low Strength
  • 9.2. Standard Strength
  • 9.3. High Strength
  • 9.4. Titrated Dose Packs

10. Yiqing Keli Market, by Indication Category

  • 10.1. Upper Respiratory Tract Infection
    • 10.1.1. Common Cold
    • 10.1.2. Acute Pharyngitis
    • 10.1.3. Acute Tonsillitis
  • 10.2. Influenza-Like Illness
    • 10.2.1. Seasonal Influenza
    • 10.2.2. Viral Fever
  • 10.3. Lower Respiratory Complications
    • 10.3.1. Acute Bronchitis
    • 10.3.2. Exacerbation of Chronic Bronchitis
  • 10.4. Preventive Use
    • 10.4.1. Immunity Support
    • 10.4.2. Post-Exposure Prophylaxis

11. Yiqing Keli Market, by End User

  • 11.1. Hospitals
  • 11.2. Clinics
    • 11.2.1. General Practitioner Clinics
    • 11.2.2. ENT Clinics
    • 11.2.3. TCM Clinics
  • 11.3. Home Use

12. Yiqing Keli Market, by Distribution Channel

  • 12.1. Hospital Pharmacies
  • 12.2. Retail Pharmacies
  • 12.3. Traditional Medicine Clinics
  • 12.4. Online Pharmacies

13. Yiqing Keli Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Yiqing Keli Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Yiqing Keli Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Yiqing Keli Market

17. China Yiqing Keli Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Anguo Yadong Biopharmaceutical Co., Ltd.
  • 18.6. Guangdong Luofushan National Pharmaceutical Co., Ltd.
  • 18.7. Guizhou Hengba Pharmaceutical Co., Ltd.
  • 18.8. Jiangxi Huiren Pharmaceutical Co., Ltd.
  • 18.9. Jiangxi Xinglin Baima Pharmaceutical Co., Ltd.
  • 18.10. Jilin Gaomiao Pharmaceutical Co., Ltd.
  • 18.11. Mengyang Pharmaceutical Co., Ltd.
  • 18.12. Qionglai Tianyin Pharmaceutical Co., Ltd.
  • 18.13. Shanxi Jinxin Shuanghe Pharmaceutical Co., Ltd.
  • 18.14. Tonghua Hongbao Pharmaceutical Co., Ltd.
  • 18.15. Tonghua Jinkaiwei Pharmaceutical Co., Ltd.
  • 18.16. Tonghua Jinma Pharmaceutical Group Co., Ltd.
  • 18.17. Yunnan Xitao Green Pharmaceutical Co., Ltd.
  • 18.18. Zhejiang Weikang Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL YIQING KELI MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL YIQING KELI MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL YIQING KELI MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL YIQING KELI MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL YIQING KELI MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL YIQING KELI MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL YIQING KELI MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES YIQING KELI MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA YIQING KELI MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL YIQING KELI MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-COATED GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-COATED GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-COATED GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-FREE GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-FREE GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-FREE GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL YIQING KELI MARKET SIZE, BY LOW-DOSE PEDIATRIC GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL YIQING KELI MARKET SIZE, BY LOW-DOSE PEDIATRIC GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL YIQING KELI MARKET SIZE, BY LOW-DOSE PEDIATRIC GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD PEDIATRIC GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD PEDIATRIC GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD PEDIATRIC GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL YIQING KELI MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL YIQING KELI MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL YIQING KELI MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL YIQING KELI MARKET SIZE, BY HARD CAPSULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL YIQING KELI MARKET SIZE, BY HARD CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL YIQING KELI MARKET SIZE, BY HARD CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL YIQING KELI MARKET SIZE, BY SOFT CAPSULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL YIQING KELI MARKET SIZE, BY SOFT CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL YIQING KELI MARKET SIZE, BY SOFT CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL YIQING KELI MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL YIQING KELI MARKET SIZE, BY ORAL SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL YIQING KELI MARKET SIZE, BY ORAL SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL YIQING KELI MARKET SIZE, BY READY-TO-DRINK SOLUTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL YIQING KELI MARKET SIZE, BY READY-TO-DRINK SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL YIQING KELI MARKET SIZE, BY READY-TO-DRINK SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL YIQING KELI MARKET SIZE, BY CONCENTRATED SOLUTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL YIQING KELI MARKET SIZE, BY CONCENTRATED SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL YIQING KELI MARKET SIZE, BY CONCENTRATED SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL YIQING KELI MARKET SIZE, BY LOW STRENGTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL YIQING KELI MARKET SIZE, BY LOW STRENGTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL YIQING KELI MARKET SIZE, BY LOW STRENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD STRENGTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD STRENGTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD STRENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL YIQING KELI MARKET SIZE, BY HIGH STRENGTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL YIQING KELI MARKET SIZE, BY HIGH STRENGTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL YIQING KELI MARKET SIZE, BY HIGH STRENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL YIQING KELI MARKET SIZE, BY TITRATED DOSE PACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL YIQING KELI MARKET SIZE, BY TITRATED DOSE PACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL YIQING KELI MARKET SIZE, BY TITRATED DOSE PACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL YIQING KELI MARKET SIZE, BY COMMON COLD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL YIQING KELI MARKET SIZE, BY COMMON COLD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL YIQING KELI MARKET SIZE, BY COMMON COLD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE PHARYNGITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE PHARYNGITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE PHARYNGITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE TONSILLITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE TONSILLITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE TONSILLITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL YIQING KELI MARKET SIZE, BY SEASONAL INFLUENZA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL YIQING KELI MARKET SIZE, BY SEASONAL INFLUENZA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL YIQING KELI MARKET SIZE, BY SEASONAL INFLUENZA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL YIQING KELI MARKET SIZE, BY VIRAL FEVER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL YIQING KELI MARKET SIZE, BY VIRAL FEVER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL YIQING KELI MARKET SIZE, BY VIRAL FEVER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE BRONCHITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE BRONCHITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE BRONCHITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL YIQING KELI MARKET SIZE, BY EXACERBATION OF CHRONIC BRONCHITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL YIQING KELI MARKET SIZE, BY EXACERBATION OF CHRONIC BRONCHITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL YIQING KELI MARKET SIZE, BY EXACERBATION OF CHRONIC BRONCHITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL YIQING KELI MARKET SIZE, BY PREVENTIVE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL YIQING KELI MARKET SIZE, BY PREVENTIVE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL YIQING KELI MARKET SIZE, BY PREVENTIVE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL YIQING KELI MARKET SIZE, BY IMMUNITY SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL YIQING KELI MARKET SIZE, BY IMMUNITY SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL YIQING KELI MARKET SIZE, BY IMMUNITY SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL YIQING KELI MARKET SIZE, BY POST-EXPOSURE PROPHYLAXIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL YIQING KELI MARKET SIZE, BY POST-EXPOSURE PROPHYLAXIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL YIQING KELI MARKET SIZE, BY POST-EXPOSURE PROPHYLAXIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL YIQING KELI MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL YIQING KELI MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL YIQING KELI MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL YIQING KELI MARKET SIZE, BY GENERAL PRACTITIONER CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL YIQING KELI MARKET SIZE, BY GENERAL PRACTITIONER CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL YIQING KELI MARKET SIZE, BY GENERAL PRACTITIONER CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL YIQING KELI MARKET SIZE, BY ENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL YIQING KELI MARKET SIZE, BY ENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL YIQING KELI MARKET SIZE, BY ENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL YIQING KELI MARKET SIZE, BY TCM CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL YIQING KELI MARKET SIZE, BY TCM CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL YIQING KELI MARKET SIZE, BY TCM CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL YIQING KELI MARKET SIZE, BY HOME USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL YIQING KELI MARKET SIZE, BY HOME USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL YIQING KELI MARKET SIZE, BY HOME USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL YIQING KELI MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL YIQING KELI MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL YIQING KELI MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL YIQING KELI MARKET SIZE, BY TRADITIONAL MEDICINE CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL YIQING KELI MARKET SIZE, BY TRADITIONAL MEDICINE CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL YIQING KELI MARKET SIZE, BY TRADITIONAL MEDICINE CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL YIQING KELI MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL YIQING KELI MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL YIQING KELI MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL YIQING KELI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS YIQING KELI MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. GLOBAL YIQING KELI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 270. GCC YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 271. GCC YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 272. GCC YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 273. GCC YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 274. GCC YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 275. GCC YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 276. GCC YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 277. GCC YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 278. GCC YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 279. GCC YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 280. GCC YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 281. GCC YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 282. GCC YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. GCC YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 284. GCC YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPEAN UNION YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPEAN UNION YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 301. BRICS YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 302. BRICS YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 303. BRICS YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 304. BRICS YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 305. BRICS YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 306. BRICS YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 307. BRICS YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 308. BRICS YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 309. BRICS YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 310. BRICS YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 311. BRICS YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 312. BRICS YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 313. BRICS YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 314. BRICS YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 315. G7 YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 316. G7 YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 317. G7 YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 318. G7 YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 319. G7 YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 320. G7 YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 321. G7 YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 322. G7 YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 323. G7 YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 324. G7 YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 325. G7 YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 326. G7 YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 327. G7 YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 328. G7 YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 329. G7 YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 330. NATO YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 331. NATO YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 332. NATO YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 333. NATO YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 334. NATO YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 335. NATO YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 336. NATO YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 337. NATO YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 338. NATO YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 339. NATO YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 340. NATO YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 341. NATO YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 342. NATO YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 343. NATO YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 344. NATO YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 345. GLOBAL YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 346. UNITED STATES YIQING KELI MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 347. UNITED STATES YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 348. UNITED STATES YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-20